Doximity stock (DOCS) Overview

Quick summary

Doximity stock (DOCS) refers to the publicly traded shares of Doximity, Inc., a U.S.-focused digital platform built for medical professionals. This article provides a structured, beginner-friendly reference covering the company overview, listing details, financial and operating metrics, analyst coverage, recent news, risks, investor resources and practical next steps for researching or trading DOCS. Read on to learn where to find authoritative data, what drives revenue for the business, which risks to monitor and how to use Bitget’s tools for market access and research.

Company overview

Doximity is a digital professional network and clinical platform serving U.S. physicians and other health-care providers. Its product suite includes a secure professional network and directory, telehealth and video visit tools, a medical newsfeed, clinical collaboration workflows, digital fax, scheduling solutions and hiring/marketing tools targeted to health systems and pharmaceutical companies.

Founded in the 2010s, Doximity built a membership base of licensed clinicians and emphasizes secure, HIPAA-compliant communication tools and clinician-centered content. The company monetizes by selling recruitment/hiring solutions, marketing and advertising to life-science firms, subscription and telehealth services to health systems and clinicians, and software tools that streamline practice operations.

Key executives typically referenced in investor materials include the CEO and CFO; for the most up-to-date names and roles, consult the company’s investor relations disclosures and proxy statements.

Stock listing and trading information

Ticker symbol and exchange

• Ticker: DOCS
• Exchange: New York Stock Exchange (NYSE)
• Trading currency: U.S. dollars (USD)
• Typical U.S. trading hours: regular session 09:30–16:00 ET; pre- and post-market sessions vary by brokerage.

Investors track DOCS quotes in USD and can view real-time or delayed quotes on major market-data providers and broker platforms.

IPO and listing history

Doximity completed its initial public offering and listing as a publicly traded company on a U.S. exchange. The IPO details — including offering date, deal size, pricing and lockup terms — are available in the company’s SEC filings and investor relations archive. Investors monitoring corporate history should review the company’s S-1 and subsequent 8-K filings for precise IPO economics and any later corporate actions.

Market data and trading statistics

Common market and trading statistics investors monitor for DOCS include market capitalization, shares outstanding, float, average daily trading volume, 52‑week high/low, and beta. These values change daily; check primary market-data providers and the company’s investor relations for up-to-date figures.

Where to find real-time and historical quotes:

• Major financial data providers (e.g., Yahoo Finance, Morningstar, CNBC, Zacks).
• Broker platforms and trading services that provide U.S. equities access — for market access and integrated tools, consider Bitget’s supported equities research and trading features.

Business model and revenue drivers

Doximity’s revenue model is multi-faceted and typically includes:

• Marketing and advertising: selling targeted advertising and promotional solutions to pharmaceutical and life-science firms that want to reach U.S. clinicians.
• Hiring and recruitment solutions: tools that help health systems and employers recruit physicians and advanced-practice clinicians.
• Telehealth and clinical products: subscription or usage-based fees for secure telehealth / video visit services and clinical workflow tools.
• SaaS-like professional tools: digital fax, scheduling, and collaboration services that enable clinicians and practices to manage patient and administrative workflows.

Monetization generally depends on continued clinician engagement, advertiser demand, the health-care hiring cycle and adoption by health systems. Investors often watch metrics such as active clinician users, bookings or contract wins in hiring/marketing verticals, telehealth visit volume and average revenue per user or customer.

Financial performance

Historical financials

Doximity’s financial reporting (quarterly and annual) covers revenue growth, gross margin, operating income/loss, net income or loss, and cash flow. Historical trends investors watch include year-over-year revenue changes, subscription vs. marketing mix shifts, and the pace at which telehealth or SaaS offerings contribute to recurring revenue. For exact revenue figures, margins and trends, consult the company’s latest Form 10-Q and Form 10-K filings.

Key financial metrics and valuation

Analysts reference metrics such as:

• Price-to-earnings (P/E) ratio when the company reports positive earnings.
• Price-to-sales (P/S) ratio for high-growth or less-profitable tech-enabled companies.
• Enterprise value to EBITDA (EV/EBITDA) to compare firms on an operational basis.
• Free cash flow and free cash flow yield.

Valuation comparisons are made with peer health-care information services and digital health companies. Because valuation metrics change with market prices and company performance, use up-to-date quotes from financial data providers and the company’s reported financials for calculation.

Ownership and shareholders

Doximity’s ownership structure typically features a mix of institutional investors, mutual funds, ETFs, and insider ownership (executive officers, directors, early investors). Public filings (Form 10‑K and Schedule 13D/G filings, as applicable) and financial data providers show large institutional holders and recent changes in ownership. Investors often review these disclosures to monitor concentration of ownership, insider buying/selling and the presence of activist or strategic shareholders.

Share classes: if Doximity has multiple share classes with differential voting rights, this will be described in the company’s charter and proxy materials. Confirm share-class structure in the company’s most recent filings.

Corporate governance and management

Corporate governance disclosures — board composition, governance practices, committee charters and executive compensation — are available in proxy statements and investor relations materials. For an investor-focused summary, review the company’s latest proxy filing which lists directors, executive officers, board committees and key governance policies.

Good governance items to check include independent director composition, executive succession plans, compensation alignment with shareholders and any related-party transactions.

Analyst coverage and market sentiment

Many equity research firms and sell-side shops publish coverage and price targets for DOCS. Analyst reports typically include revenue and earnings forecasts, target prices and buy/hold/sell opinions. Sentiment can vary; for example, some research firms may upgrade coverage based on product differentiation or survey data, while others may cite valuation concerns.

As of the most recent industry roundup, some research notes have moved on Doximity. Investors should consult consolidated analyst tables on market-data platforms or in brokerage research libraries for the latest consensus and coverage breadth.

Recent developments and news

• As of 2026-01-26, according to The Fly, Wells Fargo upgraded Doximity (DOCS) to Overweight from Equal Weight with a price target of $55 (previous target $65). The firm said its investor survey indicated Doximity has "sufficient differentiation," suggesting investor concerns may be overstated. This upgrade was part of a daily research roundup that also listed upgrades and downgrades across multiple names.

• Quarterly earnings releases, updated forward guidance, product launches (e.g., telehealth features), strategic partnerships or acquisitions are common price catalysts. For each earnings release, monitor revenue beat/miss, guidance changes, subscription growth and commentary on advertiser or hiring demand.

• When reviewing news, check reported impacts on price and volume the trading day of the announcement; many financial news feeds and market-data platforms provide intraday price reactions and volume spikes tied to specific items.

Risks and controversies

Investors should consider a range of risks tied to Doximity’s business:

• Data privacy and regulatory risk: as a platform for clinicians and patient-related workflows, Doximity must comply with HIPAA and other privacy and security requirements. Breaches or compliance failures could affect reputation and result in regulatory or legal actions.
• Competition risk: the digital health and telemedicine landscape contains other professional networks, telehealth vendors and clinical workflow tools that may compete for clinician time and institutional contracts.
• Revenue concentration: material dependence on a limited set of advertisers or large customers may present revenue concentration risk.
• Market and macro risk: broader equity market moves, interest-rate environments and sector rotation away from growth or tech-related names can affect DOCS irrespective of company fundamentals.

Any public litigation, material security incidents or regulatory inquiries will be disclosed in periodic filings; consult 8‑K reports and the company’s risk factor disclosures for named issues.

Dividend, buybacks, and capital allocation

Historically, many growth-oriented digital health firms prioritize reinvestment and product expansion over dividends. Check the company’s investor relations statements and 10‑K for any announced dividend policy, share buyback authorizations or capital allocation guidance. Management commentary in earnings calls and investor presentations will clarify priorities around cash usage, buybacks and potential M&A.

Stock tools and investor resources

Primary resources for researching DOCS include:

• Company investor relations website: for press releases, presentations, quarterly reports and proxy materials.
• SEC EDGAR filings: access Form 10‑Q, Form 10‑K, Form 8‑K and proxy statements for authoritative disclosures.
• Financial data providers: Yahoo Finance, Morningstar, CNBC, Zacks and other providers for quotes, consensus estimates and analyst coverage summaries.
• Brokerage and trading platforms: for market access, order execution, watchlists and research tools. Bitget provides market access features and research tools suitable for retail and institutional users—consider Bitget’s platform to view live quotes, research DOCS and place orders where available.

Note: always verify real-time price and trade execution with your brokerage before acting.

Historical stock performance

Price history and notable movements

Doximity stock (DOCS) has experienced multi-year price movements driven by product adoption, earnings beats or misses, and broader sector rotations in health-care technology and growth stocks. Large upward moves can coincide with better-than-expected subscriber or revenue results or favorable analyst coverage; steep declines can follow guidance reductions or macro-driven sell-offs.

When evaluating historical performance, review multi-year charts alongside revenue growth, profitability inflection points and any major corporate events (e.g., acquisitions, leadership changes) that coincide with stock moves.

Comparison with peers and indices

Analysts often compare DOCS to telehealth, healthcare IT and professional network peers using revenue growth, margin trends and valuation multiples. Also compare DOCS performance to broader indices (e.g., S&P 500) or sector indices for context on relative performance.

Regulatory filings and disclosures

Where to find filings:

• SEC EDGAR system: search for Doximity, Inc. to access all filed Forms 10‑Q, 10‑K, 8‑K, S-1 and proxy materials.

Important filings and what to look for:

• 10‑Q / 10‑K: quarterly and annual financial statements, MD&A, risk-factor updates.
• 8‑K: material events such as leadership changes, significant contracts, restatements or major financings.
• Proxy statements: board elections, executive compensation and shareholder proposals.

Disclosures to monitor: revenue recognition policies, privacy and compliance matters, material contracts and any litigation or regulatory inquiries.

See also

• Telemedicine and digital health industry overview
• Healthcare IT and clinician-facing software comparisons
• General guides to researching U.S. equities and reading SEC filings

References

Sources used and recommended for further verification and up-to-date data (no external links provided here):

• Doximity investor relations materials and SEC filings
• Yahoo Finance stock quote and company profile
• Morningstar company profile and analyst notes
• CNBC markets coverage and company summaries
• Zacks research and model summaries
• The Fly (daily research calls roundup) — cited for analyst action summary dated 2026-01-26
• Motley Fool coverage and company articles

External resources and next steps

• To verify live market data and execute trades, use an exchange-access brokerage. Bitget provides research tools, live quotes and trading capabilities; explore Bitget’s equities research features to track DOCS and related health-care technology names.

• For regulatory and legal record, retrieve the company’s filings on the SEC EDGAR database or the investor relations archive.

• If you want a quick snapshot: open the company’s latest Form 10‑Q/10‑K to confirm revenue, net income/loss, cash and cash equivalents, and management commentary.

Practical investor primer: quick checklist for researching Doximity stock

1. Confirm the current market price and volume on a reliable market-data provider or brokerage platform.
2. Read the most recent quarterly earnings release and investor presentation for subscriber and revenue trends.
3. Scan the latest 8‑K for material events since the last quarter.
4. Review analyst coverage summaries and recent price targets; note any recent upgrades or downgrades (e.g., Wells Fargo’s upgrade referenced above).
5. Examine risk-factor updates in the latest 10‑K for privacy/compliance and competitive risks.
6. Check insider trading and institutional ownership via public filings.
7. Compare valuation multiples (P/E, P/S, EV/EBITDA) to peers for relative context.

Additional notes on the research-highlighted analyst action (timely item)

• As of 2026-01-26, according to The Fly’s compilation of market-moving research calls, Wells Fargo upgraded Doximity (DOCS) to Overweight from Equal Weight and set a price target of $55 (down from a prior $65). The note referenced investor survey results indicating Doximity’s differentiation among clinician-focused platforms. This research-action was listed alongside other upgrades and downgrades across sectors on that date.

• Keep in mind analyst price targets and ratings reflect individual firms’ models and assumptions; consensus and median targets may differ. Always check the primary analyst report or firm note for the assumptions behind a rating change.

How to track live metrics mentioned in this guide

• Market capitalization, average daily volume and 52‑week range: view on real-time quote pages of major market-data providers or your brokerage dashboard.
• Institutional and insider holdings: review the company’s quarterly filings and consolidated 13F/13D data for institutional positions.
• SEC filings: EDGAR hosts definitive legal and financial disclosures.
• News flow and material events: use corporate press releases, reputable financial news services and the investor relations news feed.

Responsible use and legal notes

This article is informational and educational in nature. It does not provide investment advice, trading recommendations, or endorsements of specific investment outcomes. Readers should conduct their own due diligence, consult primary filings and consider seeking advice from licensed financial professionals before making investment decisions.

Last updated: 2026-01-26 (news and analyst item cited from The Fly).